Article Text
PostScript
Letter
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available
Statistics from Altmetric.com
Footnotes
Contributors AM and LB performed the analysis, DM and MC separately did the same analysis, and the results were compared. The four co-authors equally contributed to writing the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.